LB Pharmaceuticals Inc Company Profile
NASDAQ: LBRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
LB Pharmaceuticals at a glance
LB Pharmaceuticals Inc (NASDAQ: LBRX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in New York, NY. LB Pharmaceuticals is led by Ms. Heather D. Turner Esq., J.D. and employs about 49 people. The company's shares have traded publicly since 2025.
At a market capitalization of $1.10 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001691082, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does LB Pharmaceuticals do?
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.
Business description based on the company's public filings.
Company information
- Legal name
- LB Pharmaceuticals Inc
- Ticker
- NASDAQ: LBRX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Ms. Heather D. Turner Esq., J.D.
- Employees
- 49
- Headquarters
- One Pennsylvania Plaza, New York, NY, United States
- Phone
- 212 605 0300
- Website
- lbpharma.us
- IPO year
- 2025
- Market cap
- $1.10B
- SEC CIK
- 0001691082
Companies similar to LB Pharmaceuticals
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AMPHAmphastar Pharmaceuticals Inc. | 25.81 | +1.06% | $1.10B | vs LBRX |
| AVLNAvalyn Pharma Inc. | 25.72 | +0.74% | $1.14B | vs LBRX |
| TRAXFirst Tracks Biotherapeutics Inc. | 32.01 | +4.64% | $1.14B | vs LBRX |
| HROWHarrow Inc. | 30.52 | -0.33% | $1.14B | vs LBRX |
| NBTXNanobiotix S.A. ADR | 22.90 | -6.99% | $1.17B | vs LBRX |
| OPKOPKO Health Inc. | 1.37 | -1.44% | $1.02B | vs LBRX |
| SVRASavara Inc. | 4.83 | -1.02% | $992.37M | vs LBRX |
| AKTSAktis Oncology Inc. | 17.74 | -1.44% | $986.69M | vs LBRX |